Related Articles
Type 2 innate lymphoid cells participate in IL‑33‑stimulated Th2‑associated immune response in chronic obstructive pulmonary disease
IL‑33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway
IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway
Role of the IL‑33/ST2 receptor axis in ovarian cancer progression (Review)
Interleukin-1 receptor antagonist expression is inversely associated with outcomes of hepatitis B-related acute-on-chronic liver failure